![Frontiers | Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation Frontiers | Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation](https://www.frontiersin.org/files/Articles/462543/fimmu-10-01609-HTML/image_m/fimmu-10-01609-g001.jpg)
Frontiers | Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation
Flow diagram of study design. aPL: Antiphospholipid antibodies; APS:... | Download Scientific Diagram
![Who Is APS ACTION? APS ACTION in an international network created to design & conduct multicenter clinical trials and #r… | Clinical trials, Positivity, Thrombosis Who Is APS ACTION? APS ACTION in an international network created to design & conduct multicenter clinical trials and #r… | Clinical trials, Positivity, Thrombosis](https://i.pinimg.com/736x/2b/8a/18/2b8a18cc4799d1583ecc436789aa730b.jpg)
Who Is APS ACTION? APS ACTION in an international network created to design & conduct multicenter clinical trials and #r… | Clinical trials, Positivity, Thrombosis
Laurent ARNAUD on Twitter: "Discover the pathogenesis of the #antiphospholipid syndrome #APS and the effect of low-dose asprin in patients with aPL. https://t.co/mfzO3tyanh https://t.co/eOn4uUTavF" / Twitter
![Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort | Arthritis Research & Therapy | Full Text Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-020-2131-4/MediaObjects/13075_2020_2131_Fig1_HTML.png)
Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort | Arthritis Research & Therapy | Full Text
![Damage Accrual Measured by DIAPS in Antiphospholipid Antibody (aPL)-positive Patients: Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”) - ACR ... Damage Accrual Measured by DIAPS in Antiphospholipid Antibody (aPL)-positive Patients: Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”) - ACR ...](https://acrabstracts.org/wp-content/uploads/2021/09/ACR_1059765_1.jpg)
Damage Accrual Measured by DIAPS in Antiphospholipid Antibody (aPL)-positive Patients: Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”) - ACR ...
![Treatment in thrombotic antiphospholipid syndrome: a review - T S Vadgama, A Smith, M L Bertolaccini, 2019 Treatment in thrombotic antiphospholipid syndrome: a review - T S Vadgama, A Smith, M L Bertolaccini, 2019](https://journals.sagepub.com/cms/10.1177/0961203319864163/asset/images/large/10.1177_0961203319864163-fig1.jpeg)
Treatment in thrombotic antiphospholipid syndrome: a review - T S Vadgama, A Smith, M L Bertolaccini, 2019
![Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of “Non-criteria” Antiphospholipid Antibodies | The Journal of Rheumatology Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of “Non-criteria” Antiphospholipid Antibodies | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/44/11/1597/F1.large.jpg)
Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of “Non-criteria” Antiphospholipid Antibodies | The Journal of Rheumatology
![COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) - Xin Wang, Elena Gkrouzman, Danieli Castro Oliveira Andrade, Laura COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) - Xin Wang, Elena Gkrouzman, Danieli Castro Oliveira Andrade, Laura](https://journals.sagepub.com/cms/10.1177/09612033211062523/asset/images/large/10.1177_09612033211062523-fig1.jpeg)
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) - Xin Wang, Elena Gkrouzman, Danieli Castro Oliveira Andrade, Laura
![Seronegative antiphospholipid syndrome: refining the value of “non-criteria” antibodies for diagnosis and clinical management | Semantic Scholar Seronegative antiphospholipid syndrome: refining the value of “non-criteria” antibodies for diagnosis and clinical management | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/389cc129d5644c30c798a352a9687f99fd819b8e/8-Figure2-1.png)